RLYB

Rallybio Corp

0.43

0.02+4.40%

After Hours: 0.4299 -0.00 -0.53%16:22 07/16 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.4150/0.4140

TODAY RANGE0.4056-0.4400

VOL448.63K

MARKET CAP17.99M

52 WEEK RANGE0.2201-1.540

AVG VOL (3M)2.84M

% TURNOVER1.08%

TURNOVER--

P/E (TTM)-0.3991

% RANGE8.31%

EPS(TTM)-1.0830

P/E(FORWARD)-0.4968

P/B0.3326

BVPS1.300

DIVIDEND--

P/S28.25

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP15.93M

SHARES OUTSTANDING41.61M

NEXT EARNINGS--

FREE FLOAT36.86M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Benzinga·1d ago
12 Health Care Stocks Moving In Monday's After-Market Session
TipRanks·1d ago
Evercore ISI Remains a Hold on Rallybio (RLYB)
Simply Wall St·6d ago
We're Keeping An Eye On Rallybio's (NASDAQ:RLYB) Cash Burn Rate
Benzinga·07/09 12:07
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
The Motley Fool·07/08 17:28
Here's Why Shares in Recursion Pharmaceuticals Surged Today
Benzinga·07/08 17:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Dow Jones·07/08 15:54
Recursion Pharmaceuticals Stock Gains on Plans to Buy Drug-Development Interest from Rallybio
Benzinga·07/08 13:44
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?
TipRanks·07/08 13:12
Rallybio Stock (RLYB) Rockets 25% on a Recursion Pharmaceuticals Agreement
Seeking Alpha·07/08 12:39
Recursion to buy Rallybio’s ownership in jointly developed bone disorder drug
Dow Jones·07/08 12:34
Rallybio to Sell Drug-Development Interest to Recursion for Up to $25M
TipRanks·07/08 12:30
Rallybio Sells REV102 Program to Recursion Pharmaceuticals
TipRanks·07/08 12:16
Rallybio to sell interest in REV102 to Recursion Pharmaceuticals for up to $25M
TipRanks·07/08 12:10
Recursion Pharmaceuticals acquires full rights to hypophosphatasia drug REV102
Benzinga·07/08 12:04
Recursion Acquires Rallybio's Full Interest In Joint ENPP1 Inhibitor Program And Associated Backup Molecule For Treatment Of Hypophosphatasia; Rallybio To Receive $7.5M Upfront, With Potential For $17.5M More In Preclinical And Clinical Milestones

Same Industry

Name/Symbol

Change%

Price

Rallybio Corp

RLYB

+4.40%

0.4322

Regeneron Pharmaceuticals

REGN

-0.01%

547.93

Entero Therapeutics

ENTO

-4.04%

0.4510

BIONTECH

BNTX

+1.66%

112.49

United Therapeutics Corp.

UTHR

+1.68%

298.16

Siga Technologie

SIGA

+1.19%

6.78

Vertex Pharmaceuticals Inc

VRTX

+1.15%

469.55

Moderna

MRNA

+1.52%

32.06

Charles Riv Labs Intl Inc

CRL

+0.34%

154.94

Medpace Holdings

MEDP

+0.68%

314.83

Talphera Inc

TLPH

-1.69%

0.4300

ICON PLC

ICLR

-1.06%

144.04

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

+0.61%

158.64

MOLECULAR PARTNERS AG

MOLN

+2.24%

3.65

Gilead Sciences Inc

GILD

+0.72%

109.85

Arcturus Therape

ARCT

-2.28%

12.85

PRA Health

PRAH

165.21

Incyte Corp

INCY

+1.44%

69.23

Aptevo Therapeutics Inc

APVO

+3.77%

3.03

Biospecifics

BSTC

+0.15%

88.53